Drug Profile
Research programme: cardiovascular disorders therapeutics - InVasc Therapeutics
Alternative Names: INV 40-69; INV 55-05; INV 55-06; INV 65-05; INV 65-06; INV 70-65; INV 74-65; INV-065Latest Information Update: 06 Jul 2011
Price :
$50
*
At a glance
- Originator InVasc Therapeutics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Atherosclerosis; Metabolic syndrome; Peripheral arterial disorders
Most Recent Events
- 01 Apr 2008 Preclinical trials in Atherosclerosis in USA (unspecified route)
- 01 Apr 2008 Preclinical trials in Metabolic syndrome in USA (unspecified route)
- 01 Apr 2008 Preclinical trials in Peripheral arterial disorders in USA (unspecified route)